Cancer Research Institute honors UCLA scientist for basic, tumor immunology discoveries

Antoni Ribas, MD, PhD
Antoni Ribas

The Cancer Research Institute presented the William B. Coley Award to Antoni Ribas, MD, PhD.

The award — named after a bone surgeon and cancer researcher credited with using the first immunotherapy to save a patient with inoperable cancer in 1891 — recognizes a scientist for seminal discoveries in basic immunology or tumor immunology.

Ribas, professor of medicine at David Geffen School of Medicine at University of California, Los Angeles — was selected for his efforts leading the clinical program that demonstrated the effectiveness of checkpoint inhibitors, his development of stem cell-based adoptive cell therapies, and his research that helped identify biomarkers of response and acquired resistance to PD-1 blockade therapies.

Ribas also serves as director of UCLA Parker Institute for Cancer Immunotherapy Center and as a member of Broad Stem Cell Research Center at UCLA.

Antoni Ribas, MD, PhD
Antoni Ribas

The Cancer Research Institute presented the William B. Coley Award to Antoni Ribas, MD, PhD.

The award — named after a bone surgeon and cancer researcher credited with using the first immunotherapy to save a patient with inoperable cancer in 1891 — recognizes a scientist for seminal discoveries in basic immunology or tumor immunology.

Ribas, professor of medicine at David Geffen School of Medicine at University of California, Los Angeles — was selected for his efforts leading the clinical program that demonstrated the effectiveness of checkpoint inhibitors, his development of stem cell-based adoptive cell therapies, and his research that helped identify biomarkers of response and acquired resistance to PD-1 blockade therapies.

Ribas also serves as director of UCLA Parker Institute for Cancer Immunotherapy Center and as a member of Broad Stem Cell Research Center at UCLA.

    See more from Immuno-Oncology Resource Center